Skip to main content

First, let's get one thing straight -- everybody is afraid.

Suddenly it is not just



-specific. It is not just

BMC Software


-specific. It is not just interest-rate-specific. And it is not just


(LU) - Get Lufax Holding Ltd American Depositary Shares two of which representing one Report

-specific. The selloff has merit, makes sense, is not irrational, and can be justified by bull and bear alike.

Second, the Lucent conference call, while very clearly indicating that


was not a problem, can't allay fears because it is layered on top of these other recent disappointments. And this, of course, is layered on top of the greatest fourth quarter anybody can ever remember.

Third, we could still fall considerably and barely (


Scroll to Continue

TheStreet Recommends

, please note that in the first draft that came out "bearly") dent that colossal gain we had last year.

Fourth, it would be enough just to fret about how the payroll number might be because, as everyone knows, the


wants growth to be slower than it is.


Cramer Berkowitz

, we have cash both coming in and on the sidelines. We feel confident that we can continue to put money to work in the Lucent-created downturn.

We are split, however, on where to go. I was arguing last night that maybe we need to buy some safety first before we average in more on tech. If


(CL) - Get Colgate-Palmolive Company Report



(PG) - Get Procter & Gamble Company (The) Report

come down off of the futures, that should be our first buy. A


(KMB) - Get Kimberly-Clark Corporation Report

would fit that bill.

Jeff Berkowitz

likes to buy distressed merchandise of nondistressed companies. Confident -- post-Lucent -- that telco demand and semiconductor demand is still strong, he is drawn toward "multiple" tech, or tech that sells at a multiple to earnings.

Cramer's Latest: Join the discussion on


message boards

Lucent (LU)

I am actually more confident that the

B2Bs and the New Tech 30 (formerly the Red Hots) have corrected enough to add to those positions, as we only have token amounts.

Neither one of us, of course, is so certain that we can sit here and say, "You have to buy this or that." If we were, we would be robots with a script.

Nevertheless, as we rap up our calls on Lucent we come down strongly on the side that says that the real earnings season will soon be upon us and we will regret selling our basic core tech at these prices -- even though they are up substantially from last year at this time.

I wish I could exude confidence right now; I know many people wish I would. But in the end, I am a portfolio manager struggling to make sense with a lot of unknowable items.

I came in with cash at the beginning of the year, not expecting, but actually hoping for, a dip to get in. I did not expect a chasm. But now that it is upon us, I am not going to turn tail.

That's not how the game is played.

James J. Cramer is manager of a hedge fund and co-founder of At time of publication, his fund had no positions in any stocks mentioned. His fund often buys and sells securities that are the subject of his columns, both before and after the columns are published, and the positions that his fund takes may change at any time. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Cramer's writings provide insights into the dynamics of money management and are not a solicitation for transactions. While he cannot provide investment advice or recommendations, he invites you to comment on his column at